Atlas Venture Associates X, LLC, 10% Owner at Kymera Therapeutics, Inc. (KYMR), sold 242,133 shares at $61.00 ($14.8M) on 2021-08-11, disclosed to the SEC on 2021-08-12.
Open-market sale of $14.8M KYMR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GBIO | SELL | 2021-09-24 | $7.0M | — | Filing → |
| GBIO | SELL | 2021-04-14 | $7.3M | — | Filing → |
| GBIO | SELL | 2021-04-09 | $7.2M | — | Filing → |